Published in Mol Immunol on July 30, 2008
Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol (2012) 2.24
Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res (2010) 1.78
B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest (2009) 1.37
IgM promotes the clearance of small particles and apoptotic microparticles by macrophages. PLoS One (2011) 0.91
Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol (2010) 0.91
Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis. Front Immunol (2013) 0.89
Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. FASEB J (2014) 0.87
Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. J Immunol (2010) 0.86
Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol (2009) 0.83
TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage. Am J Clin Exp Immunol (2012) 0.81
The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability. F1000Res (2015) 0.79
Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice. Surgery (2009) 0.78
Ischemia/Reperfusion. Compr Physiol (2016) 0.78
Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury. Clin Immunol (2014) 0.77
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front Immunol (2016) 0.77
Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus. Arthritis Rheumatol (2017) 0.77
CD6 regulates intestinal ischemia/reperfusion-induced injury by modulating natural IgM-producing B1a cell self-renewal. J Biol Chem (2016) 0.76
Natural antibody - Biochemistry and functions. Glob J Biochem (2011) 0.76
Prevention of intestinal ischemia-reperfusion injury in humanized mice. Surgery (2016) 0.75
The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications. J Am Soc Nephrol (2016) 0.75
Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg (1970) 5.62
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2004) 2.30
Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol (2005) 2.02
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol (2005) 1.89
Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol (1986) 1.83
Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol (2006) 1.78
Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest (1975) 1.59
Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol (2002) 1.58
Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology (2006) 1.30
Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol (2002) 1.29
The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol (2006) 1.22
Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res (1998) 1.18
Natural antibody mediated innate autoimmune response. Mol Immunol (2006) 1.17
Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery (2004) 1.16
Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery (2006) 1.15
Intestinal mucosal lesion in low-flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch Surg (1970) 1.11
Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol (1993) 1.04
IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol (2005) 0.95
Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man. J Pathol (2000) 0.85
Complement activation in patients with acute myocardial infarction treated with streptokinase. Am J Med Sci (1998) 0.84
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
B cell receptor signal strength determines B cell fate. Nat Immunol (2004) 3.06
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity (2009) 2.98
Bacteria activate sensory neurons that modulate pain and inflammation. Nature (2013) 2.56
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2004) 2.30
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A (2008) 2.26
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol (2012) 2.17
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity (2011) 2.11
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol (2007) 2.09
Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes. Nat Immunol (2010) 1.97
A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep (2013) 1.92
Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci (2008) 1.78
Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res (2010) 1.78
Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol (2006) 1.78
T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity (2004) 1.53
Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity (2012) 1.50
Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. Immunity (2013) 1.50
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood (2012) 1.48
Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev (2007) 1.45
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol (2006) 1.38
Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A (2009) 1.33
B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med (2002) 1.32
Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol (2002) 1.29
F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med (2003) 1.28
Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun (2002) 1.24
The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol (2006) 1.22
Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci U S A (2005) 1.21
Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo. Immunity (2002) 1.19
Natural antibody mediated innate autoimmune response. Mol Immunol (2006) 1.17
The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol (2006) 1.17
Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery (2004) 1.16
Trafficking of B cell antigen in lymph nodes. Annu Rev Immunol (2011) 1.15
Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery (2006) 1.15
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc Natl Acad Sci U S A (2006) 1.14
Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol (2003) 1.14
B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol (2010) 1.14
Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J Immunol (2003) 1.11
Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity (2013) 1.11
Emerging patterns in complement-mediated pathogen recognition. Cell (2006) 1.09
Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia. Glia (2012) 1.07
Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J Immunol (2005) 1.06
Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice. Int Immunol (2004) 1.03
Transcriptional basis of lymphocyte tolerance. Immunol Rev (2006) 1.01
Innate response to self-antigen significantly exacerbates burn wound depth. Proc Natl Acad Sci U S A (2007) 1.00
Complement C4 is protective for lupus disease independent of C3. J Immunol (2002) 0.98
Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4. J Cereb Blood Flow Metab (2007) 0.98
Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. J Immunol (2002) 0.94
Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice. J Cereb Blood Flow Metab (2008) 0.94
Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol (2002) 0.94
Complement and natural antibody are required in the long-term memory response to influenza virus. Vaccine (2008) 0.93
A role for complement in feedback enhancement of antibody responses by IgG3. J Exp Med (2003) 0.92
SAP expression in invariant NKT cells is required for cognate help to support B-cell responses. Blood (2012) 0.92
B cell acquisition of antigen in vivo. Curr Opin Immunol (2009) 0.92
Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect Immun (2003) 0.91
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A (2011) 0.90
Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol (2006) 0.90
Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury. Expert Opin Biol Ther (2007) 0.90
Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model. Arthritis Rheum (2007) 0.89
Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cells. J Exp Med (2010) 0.88
Follicular exclusion of autoreactive B cells requires FcgammaRIIb. Int Immunol (2007) 0.87
CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol (2005) 0.85
T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology (2006) 0.84
Involvement of NFAT1 in B cell self-tolerance. J Immunol (2006) 0.84
Complement-dependent transport of antigen into B cell follicles. J Immunol (2010) 0.82
L-Rhamnose-containing supramolecular nanofibrils as potential immunosuppressive materials. Org Biomol Chem (2014) 0.82
Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci U S A (2009) 0.82
B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells. Blood (2006) 0.79
The role of innate immunity in B cell acquisition of antigen within LNs. Adv Immunol (2010) 0.79
The presence of MOMA-2+ macrophages in the outer B cell zone and protection of the splenic micro-architecture from LPS-induced destruction depend on secreted IgM. Eur J Immunol (2007) 0.79
Contextual analysis of immunological response through whole-organ fluorescent imaging. Lymphat Res Biol (2013) 0.78
Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice. Surgery (2009) 0.78
C3d regulates immune checkpoint blockade and enhances antitumor immunity. JCI Insight (2017) 0.77
Atypical gout in the foot and ankle secondary to primary hyperparathyroidism. J Am Podiatr Med Assoc (2007) 0.75